Surviving HIV and dying for a smoke: Implications for tobacco use among people living with HIV

Hdl Handle:
http://hdl.handle.net/10675.2/614943
Title:
Surviving HIV and dying for a smoke: Implications for tobacco use among people living with HIV
Authors:
Culbreth, Rachel; Kelly, Jane; Maggio, David; Wortley, Pascale; Drenzek, Cherie
Abstract:
Background: Since the advent of highly active antiretroviral therapy in the mid-nineties, deaths among persons living with HIV (PLWH) have declined nationally. Now a controllable condition, HIV has become a chronic disease, highlighting the importance of tobacco cessation in lowering morbidity and premature mortality. Current smoking is approximately twice as high among PLWH compared with the general population. PLWH who smoke experience higher rates of cardiovascular disease, AIDS-defining illnesses, and cancer than PLWH who do not smoke. Loss of life-years associated with smoking among PLWH is greater than life-years lost from HIV. Methods: Data on current smoking, derived from the 2009-12 Georgia Medical Monitoring Project (MMP) were analyzed. Smoking rates were calculated by demographic characteristics, and results were compared to those from the 2011 Georgia Behavioral Risk Factor Surveillance System (BRFSS), a population-based telephone survey. Results: The prevalence of current smoking among PLWH was 36.1%, compared with 21.2% among the general population in Georgia. Smoking prevalence for PLWH generally varied by demographic characteristics according to the same pattern as for the general population, but prevalence was consistently higher among PLWH. Conclusions: The prevalence of current smoking among PLWH in Georgia is high. Clinical and public health interventions must address smoking cessation as part of HIV care to prevent disease, improve quality of life, and reduce mortality. HIV-infected smokers have more barriers to quitting (alcohol, depression, drug dependence, and inaccurate risk perception) and a lower quit rate than non-HIV-infected smokers. Efficacy studies of behavioral and pharmacological interventions for smoking cessation specific to PLWH are needed.
Affiliation:
Georgia Department of Public Health HIV/AIDS Epidemiology Section
Publisher:
Georgia Public Health Association
Journal:
Journal of the Georgia Public Health Association
Issue Date:
2015
URI:
http://hdl.handle.net/10675.2/614943
Additional Links:
http://www.gapha.org/jgpha/jgpha-archives/
Type:
Article
Language:
en_US
Appears in Collections:
jGPHA Volume 5, Number 1 (2015)

Full metadata record

DC FieldValue Language
dc.contributor.authorCulbreth, Rachelen
dc.contributor.authorKelly, Janeen
dc.contributor.authorMaggio, Daviden
dc.contributor.authorWortley, Pascaleen
dc.contributor.authorDrenzek, Cherieen
dc.date.accessioned2016-06-28T19:35:18Z-
dc.date.available2016-06-28T19:35:18Z-
dc.date.issued2015-
dc.identifier.urihttp://hdl.handle.net/10675.2/614943-
dc.description.abstractBackground: Since the advent of highly active antiretroviral therapy in the mid-nineties, deaths among persons living with HIV (PLWH) have declined nationally. Now a controllable condition, HIV has become a chronic disease, highlighting the importance of tobacco cessation in lowering morbidity and premature mortality. Current smoking is approximately twice as high among PLWH compared with the general population. PLWH who smoke experience higher rates of cardiovascular disease, AIDS-defining illnesses, and cancer than PLWH who do not smoke. Loss of life-years associated with smoking among PLWH is greater than life-years lost from HIV. Methods: Data on current smoking, derived from the 2009-12 Georgia Medical Monitoring Project (MMP) were analyzed. Smoking rates were calculated by demographic characteristics, and results were compared to those from the 2011 Georgia Behavioral Risk Factor Surveillance System (BRFSS), a population-based telephone survey. Results: The prevalence of current smoking among PLWH was 36.1%, compared with 21.2% among the general population in Georgia. Smoking prevalence for PLWH generally varied by demographic characteristics according to the same pattern as for the general population, but prevalence was consistently higher among PLWH. Conclusions: The prevalence of current smoking among PLWH in Georgia is high. Clinical and public health interventions must address smoking cessation as part of HIV care to prevent disease, improve quality of life, and reduce mortality. HIV-infected smokers have more barriers to quitting (alcohol, depression, drug dependence, and inaccurate risk perception) and a lower quit rate than non-HIV-infected smokers. Efficacy studies of behavioral and pharmacological interventions for smoking cessation specific to PLWH are needed.en
dc.language.isoen_USen
dc.publisherGeorgia Public Health Associationen
dc.relation.urlhttp://www.gapha.org/jgpha/jgpha-archives/en
dc.subjectHIVen
dc.subjectChronic Diseaseen
dc.subjecttobacco useen
dc.subjectpremature mortalityen
dc.titleSurviving HIV and dying for a smoke: Implications for tobacco use among people living with HIVen_US
dc.typeArticleen
dc.contributor.departmentGeorgia Department of Public Health HIV/AIDS Epidemiology Sectionen
dc.identifier.journalJournal of the Georgia Public Health Associationen
dc.contributor.affiliationGeorgia State Universityen
dc.contributor.affiliationGeorgia Department of Public Healthen
All Items in Scholarly Commons are protected by copyright, with all rights reserved, unless otherwise indicated.